Tag: drug approval

September 28, 2022
Auvelity Approved for Major Depressive Disorder

This antidepressant can yield results as soon as one week, which could generate popularity.

READ MORE
July 30, 2022
There Is No “Set it and Forget It” Amid Prescription Drug Trends

As opioid prescribing continues to decline, more nuanced and population-specific drug trends emerge as cost drivers.

READ MORE
March 28, 2022
FDA Approves Fleqsuvy for Spasticity

A new muscle relaxant for the treatment of spasticity, including from spinal cord injuries.

READ MORE
January 17, 2022
FDA Approves Yusimry as a Biosimilar to Humira

This autoimmune drug was approved for various arthritic and autoimmune diseases.

READ MORE
November 17, 2021
FDA Approves Zimhi and Seglentis

A new naloxone drug and a new opioid-NSAID combination.

READ MORE
October 21, 2021
New Drugs, Generics, and a COVID-19 Treatment Update

A new migraine medication, various generics, and more.

READ MORE
September 24, 2021
FDA Approves Pfizer COVID-19 Vaccine, Booster Shots on the Way

The Pfizer vaccine receives full FDA approval, while a new EUA authorizes booster shots for certain populations.

READ MORE
August 5, 2021
New Generic Approvals

The FDA approved first-time generics for Xeljanz, two COPD medications, and more.

READ MORE
February 9, 2021
FDA Approves Posimir for Post-Surgical Pain Relief

A novel bupivacaine formulation works as a 72-hour local anesthetic following shoulder surgery.

READ MORE
November 30, 2020
FDA Approves Veklury for COVID-19, Issues EUA for Bamlanivimab

Veklury is approved for hospitalized patients, while bamlanivimab is being investigated in mild-to-moderate cases of COVID-19.

READ MORE
lockenvelopephone-handsetmenucross-circle